Eric Larson, Executive Director of the Group Health Research Institute

2:35 – 3:25 P.M.

Panel Discussion

3:25 – 4:05 P.M.

Roundtable and Audience Discussion

4:05 – 4:20 P.M.

BREAK

4:20 – 5:20 P.M.

STRATEGIES FOR MOVING FORWARD

 

Moderator: Sharon Terry, President and Chief Executive Officer of Genetic Alliance

4:20 – 5:20 P.M.

Stakeholder Reaction Panelists

 

Robert L. Becker, Jr., Chief Medical Officer for the Office of In Vitro Diagnostic Device Evaluation and Safety, Center for Devices and Radiological Health, U.S. Food and Drug Administration

Dan Hayes, Clinical Director of the Breast Oncology Program and Stuart B. Padnos Professor in Breast Cancer Research, University of Michigan Comprehensive Cancer Center

Roger Klein, Director of the Molecular Oncology Laboratory at BloodCenter of Wisconsin and Clinical Assistant Professor of Pathology at the Medical College of Wisconsin

Margaret Piper, Director of Genomics Resources for the Blue Cross and Blue Shield Technology Evaluation Center

5:20 – 5:50 P.M.

SUMMARY AND CONCLUSIONS

5:20 – 5:50 P.M.

Review and Conclusions

 

Debra Leonard, Professor and Vice Chair for Laboratory Medicine, Director of the Clinical Laboratories, Director of the Pathology Residency Training Program, Weill Cornell Medical Center of Cornell University



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement